Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly gemcitabine + cisplatin versus weekly cisplatin with concurrent radiotherapy for locally advanced cervical cancer
ISRCTN29976507Phase 2Terminated
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Cervical Cancer (CC) comparing Weekly cisplatin with concurrent radiotherapy with Weekly gemcitabine + cisplatin with concurrent radiotherapy (2 arms). Primary endpoint: Two-year disease-free survival. Started Nov 2006; status: terminated.
02
Drugs
cisplatingemcitabine
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ISRCTN29976507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN29976507.